KARISA TOBON: Open Payments
NPI 1376165100 · TORRINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 34 payments from 13 companies in 2025. Trend: 2023 $1,468 · 2024 $1,718 · 2025 $887
Food & beverage: $887
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $173 |
| Novartis Pharmaceuticals Corporation | 7 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $116 |
| PFIZER INC. | 4 | $91 |
| Merck Sharp & Dohme LLC | 3 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| Amgen Inc. | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $27 |
Products named: CARDIOMEMS, LEQVIO, Kerendia, VERQUVO, VYNDAQEL, JARDIANCE, ELIQUIS, Repatha.
Industry payments across CT — which companies pay providers there.
